<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03967483</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A00406-51</org_study_id>
    <nct_id>NCT03967483</nct_id>
  </id_info>
  <brief_title>Study on Indomethacin-responsive Headaches</brief_title>
  <official_title>Non Interventional Study on Indomethacin-responsive Headaches</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anne Ducros</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>French Society for the Study of Migraine Headache</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Description of modalities concerning the patient care of headaches sensible to indometacine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Description of clinical profile, treatment of crisis and background treatment
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of headaches sensible to indometacine</measure>
    <time_frame>24 monthes</time_frame>
    <description>Description of the clinical cases with headaches sensible to indometacine according to the type of headaches.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Headache, Migraine</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indometacin</intervention_name>
    <description>patient who are taken indomatacin for headaches and migraine</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient sufffuring from headaches or migraine and who is receiving Indometacine
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with a diagnosis of migraine with or without aura, or trigemino-autosomic
             headaches or other primary headaches

          -  patient who are taking indometacine

          -  patient with written consent form

        Exclusion Criteria:

          -  patient under 18 years

          -  pregnant woman or breastfeeding patient

          -  patient who refuses to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anne DONNET</last_name>
    <phone>0491384340</phone>
    <email>Anne.DONNET@ap-hm.fr</email>
  </overall_contact>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 27, 2019</study_first_submitted>
  <study_first_submitted_qc>May 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>May 27, 2019</last_update_submitted>
  <last_update_submitted_qc>May 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>French Society for the Study of Migraine Headache</investigator_affiliation>
    <investigator_full_name>Anne Ducros</investigator_full_name>
    <investigator_title>Pr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Indomethacin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

